Price increases for functional polymers for pharmaceutical applications
The company’s priority is to enhance the quality and availability of supply and services. In this context significant investments were made to improve reliability, and to satisfy more stringent regulatory requirements. Additionally, increased wages and raw material costs are already above pre 2009 levels.
These investments will further improve the company’s infrastructure, strengthen business continuity and create competitive advantages for its pharmaceutical customers.
Most read news
Topics
Organizations
Other news from the department price development
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.